Health Care
Issues related to veterans access to healthcare and VA CHOICE Act reauthorization.

S. 2372, The VA MISSION Act Issues related to CVS Health announced merger with Aetna. Issues related to health savings accounts, the health insurance tax and other taxes included in the Affordable Care Act.

H.R. 5138, The Bipartisan HSA Improvement Act of 2018
H.R. 5963, To delay the reimposition of the annual fee on health insurance providers until after 2020 Issues related to barriers to generic drug and biosimilar market entry including pay-for-delay and REMS.

S. 124, The Preserve Access to Affordable Generics Act of 2017
S.771/H.R. 1776, The Improving Access to Affordable Prescription Drugs Act of 2017
H.R. 2051, The Fair Access for Safe and Timely Generics Act of 2017
S. 974/H.R. 2212, The Creating and Restoring Equal Access to Equivalent Samples Act of 2017 Issues related to implementation and changes to the Affordable Care Act. Issues related to prescription drug abuse and Medicare Part D.

S.413/H.R. 1039, The Improving Transparency and Accuracy in Medicare Part D Spending Act of 2017
H.R.1316, The Prescription Drug Price Transparency Act of 2017
S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017
S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018
H.R. 4841, The Standardizing Electronic Prior Authorization for Safe Prescribing Act
H.R. 5958, The Phair Pricing Act of 2018 Issues related to prescription drug abuse, medication adherence, drug price transparency, and gag clauses.

H.R. 1316, The Prescription Drug Price Transparency Act of 2017
S. 778/H.R. 1854, The Prescription Drug Monitoring Act of 2017
S. 2460/H.R. 3528, The Every Prescription Conveyed Securely Act of 2017
S. 892/H.R. 4408, The Opioid Addiction Prevention Act of 2017
S. 2456/H.R. 5311, The CARA 2.0 Act of 2018
S. 2553/H.R. 6144, The Know the Lowest Price Act of 2018
S. 2554/H.R. 6143, The Patient Right to Know Drug Prices Act of 2018
H.R. 5343, The Prescription Transparency Act of 2018
H.R. 6, The SUPPORT for Patients and Communities Act of 2018
H.R. 6133, The Informing Opioid Prescribing Through Evidence-Based Guidelines Act of 2018
VET - Veterans LBR - Labor Issues/Antitrust/Workplace TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid PHA - Pharmacy
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office
CVS HEALTH (AND SUBSIDIARIES)
1275 Pennsylvania Avenue, NW, Suite 700, Washington, DC, 20004, US
SHANNON PENBERTHY AMY ROSENBAUM SHANNON PENBERTHY MELISSA SCHULMAN ELIZABETH BROOKS ASHLI PALMER TEGAN GELFAND AMY ROSENBAUM SHANNON PENBERTHY TEGAN GELFAND SHANNON PENBERTHY MELISSA SCHULMAN ELIZABETH BROOKS ASHLI PALMER AMY ROSENBAUM TEGAN GELFAND ELIZABETH BROOKS SHANNON PENBERTHY ASHLI PALMER AMY ROSENBAUM TEGAN GELFAND ELIZABETH BROOKS SHANNON PENBERTHY ASHLI PALMER AMY ROSENBAUM TEGAN GELFAND MELISSA SCHULMAN ELIZABETH BROOKS SHANNON PENBERTHY ASHLI PALMER TEGAN GELFAND AMY ROSENBAUM